Literature DB >> 8891067

The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes.

I Higuchi1, K Hashimoto, E Matsuoka, R Rosales, M Nakagawa, K Arimura, S Izumo, M Osame.   

Abstract

We have analyzed muscle biopsy specimens from polymyositis patients who are also positive for human T cell lymphotropic virus type I (HTLV-I) using both immunohistochemistry for surface antigens of lymphocytes and macrophages and in situ polymerase chain reaction for HTLV-I proviral DNA on the same sections. We found HTLV-I in CD4+ cells but not in macrophages. This finding suggests that most of the HTLV-I-containing CD4+ cells are not macrophages but lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891067     DOI: 10.1007/s004010050530

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  5 in total

1.  Update on Neurological Manifestations of HTLV-1 Infection.

Authors:  Abelardo Q-C Araujo
Journal:  Curr Infect Dis Rep       Date:  2015-02       Impact factor: 3.725

Review 2.  Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.

Authors:  C R Bangham; S E Hall; K J Jeffery; A M Vine; A Witkover; M A Nowak; D Wodarz; K Usuku; M Osame
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

3.  Dynamic acquisition of HTLV-1 tax protein by mononuclear phagocytes: Role in neurologic disease.

Authors:  Eiji Matsuura; Yoshimi Enose-Akahata; Karen Yao; Unsong Oh; Yuetsu Tanaka; Hiroshi Takashima; Steven Jacobson
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

4.  Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.

Authors:  Simona Ozden; Vincent Mouly; Marie-Christine Prevost; Antoine Gessain; Gillian Butler-Browne; Pierre-Emmanuel Ceccaldi
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.

Authors:  Simona Ozden; Madeleine Cochet; Jacqueline Mikol; Antonio Teixeira; Antoine Gessain; Claudine Pique
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.